Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.9B |
| 2 |
Boeing
BA
|
+$956M |
| 3 |
Netflix
NFLX
|
+$804M |
| 4 |
EOG Resources
EOG
|
+$761M |
| 5 |
Wells Fargo
WFC
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$1.3B |
| 2 |
Nike
NKE
|
+$1.17B |
| 3 |
AbbVie
ABBV
|
+$1.16B |
| 4 |
McDonald's
MCD
|
+$1.15B |
| 5 |
Texas Instruments
TXN
|
+$987M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.27% |
| 2 | Technology | 16.8% |
| 3 | Communication Services | 12.6% |
| 4 | Consumer Discretionary | 11.05% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
CONMED
CNMD
$1.48B
| $241M | 0.07% |
2,156,651
-113,511
| -5% | -$12.1M |
|
202
ConocoPhillips
COP
$151B
| $240M | 0.07% |
3,687,817
+3,866
| +0.1% | +$227K |
|
203
Workday
WDAY
$43.8B
| $235M | 0.07% |
1,429,237
-3,329,386
| -70% | -$553M |
|
204
Exelon
EXC
$46.9B
| $224M | 0.07% |
6,877,103
+4,185
| +0.1% | +$135K |
|
|
EA
205
DELISTED
Electronic Arts
EA
| $222M | 0.07% |
2,062,811
+1,277
| +0.1% | +$127K |
|
|
ACC
206
DELISTED
American Campus Communities, Inc.
ACC
| $218M | 0.07% |
4,637,848
+1,188
| +0% | +$56.8K |
|
207
West Pharmaceutical
WST
$24.6B
| $216M | 0.06% |
1,438,129
+1,216
| +0.1% | +$177K |
|
208
Xcel Energy
XEL
$49.4B
| $214M | 0.06% |
3,371,543
+3,378
| +0.1% | +$211K |
|
209
Wyndham Hotels & Resorts
WH
$5.5B
| $203M | 0.06% |
3,224,500
+85,000
| +3% | +$4.72M |
|
210
Lam Research
LRCX
$418B
| $202M | 0.06% |
6,923,000
-738,860
| -10% | -$19.6M |
|
211
Boston Scientific
BSX
$74.8B
| $202M | 0.06% |
4,465,937
+7,170
| +0.2% | +$300K |
|
212
XP
XP
$8.07B
| $199M | 0.06% |
+5,164,688
| New | +$194M |
|
213
IBM
IBM
$223B
| $193M | 0.06% |
1,509,938
+1,878
| +0.1% | +$244K |
|
214
Caterpillar
CAT
$392B
| $191M | 0.06% |
1,292,099
+793
| +0.1% | +$111K |
|
215
Estee Lauder
EL
$31.8B
| $190M | 0.06% |
+921,305
| New | +$179M |
|
|
AZUL
216
DELISTED
Azul
AZUL
| $184M | 0.06% |
4,296,315
-2,385,201
| -36% | -$91.8M |
|
|
IPHI
217
DELISTED
INPHI CORPORATION
IPHI
| $183M | 0.05% |
2,471,873
-84,444
| -3% | -$5.8M |
|
218
Novartis
NVS
$290B
| $181M | 0.05% |
1,912,635
+3,839
| +0.2% | +$344K |
|
219
Ametek
AME
$58.9B
| $180M | 0.05% |
1,802,563
-1,713,657
| -49% | -$162M |
|
220
US Bancorp
USB
$102B
| $178M | 0.05% |
3,003,841
+2,054
| +0.1% | +$119K |
|
221
Edison International
EIX
$27.3B
| $173M | 0.05% |
2,292,402
+697,452
| +44% | +$49.3M |
|
222
Dine Brands
DIN
$455M
| $170M | 0.05% |
2,039,724
+240,509
| +13% | +$18.7M |
|
223
Allogene Therapeutics
ALLO
$708M
| $170M | 0.05% |
6,542,678
+1,268,228
| +24% | +$34.9M |
|
224
LivaNova
LIVN
$4.49B
| $166M | 0.05% |
2,205,946
-164,772
| -7% | -$12.5M |
|
225
Petrobras Class A
PBR.A
$103B
| $158M | 0.05% |
10,577,961
-4,147,579
| -28% | -$58.8M |
|
Similar funds
Capital Research Global Investors's Q4 2019 Portfolio in Review
As of Q4 2019, Capital Research Global Investors held 433 positions worth $333B, up 9.4% from $305B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Research Global Investors's Q4 2019 filing shows 19 new, 239 increased, 105 reduced and 28 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 415,754 shares worth $490M. The largest sale was Fidelity National Information Services, an estimated $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 415,754 shares worth $490M.
- Capital Research Global Investors added most to UnitedHealth in Q4 2019, an estimated $1.9B increase.
- Capital Research Global Investors's biggest Q4 2019 reduction was Fidelity National Information Services, cutting an estimated $1.3B.
- Capital Research Global Investors fully exited 3M in Q4 2019, selling an estimated $654M.
- Capital Research Global Investors's ten largest holdings make up 30% of its $333B portfolio in Q4 2019.
- Capital Research Global Investors opened 19 new positions and closed 28 in Q4 2019.
- Capital Research Global Investors's portfolio value rose 9.4% quarter-over-quarter to $333B.
Based on Capital Research Global Investors's 13F filing for Q4 2019, filed 18 Feb 2020.